Rheumatoid arthritis (refractory) - rituximab

Rituximab, when given together with methotrexate (another drug used to treat rheumatoid arthritis), is recommended as a possible treatment for adults with severe active rheumatoid arthritis only if: the person has already tried drugs known as disease-modifying anti-rheumatic drugs to treat their ...

Read the complete summary

Rituximab, when given together with methotrexate (another drug used to treat rheumatoid arthritis), is recommended as a possible treatment for adults with severe active rheumatoid arthritis only if:

• the person has already tried drugs known as disease-modifying anti-rheumatic drugs to treat their rheumatoid arthritis, one of which must have been an ‘anti-TNF’ drug, but these haven’t worked or weren’t suitable
• it clearly improves the person’s condition, and doesn’t need to be given more often than every 6 months
• treatment is supervised by an experienced doctor who specialises in rheumatoid arthritis.

hide